Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

COR

Cencora Inc

Sep 12 • 04:00PM ET

302.52

-0.28 -0.09 %

Healthcare • Medical Distribution • USA • NYSE

Peers: CAH MCK HSIC OMI PDCO DXCM BIO HCA LH

| Held by: VTI VOO VO SPY IVV VTV IWP XLV USMV VOE

Scroll to Statements

Index	S&P 500	P/E	31.12	EPS (ttm)	9.72	Insider Own	4.22%	Shs Outstand	193.86M	Perf Week	3.43%
Market Cap	58.65B	Forward P/E	17.36	EPS next Y	17.43	Insider Trans	-1.58%	Shs Float	185.70M	Perf Month	3.94%
Enterprise Value	64.85B	PEG	2.68	EPS next Q	3.79	Inst Own	93.93%	Short Float	3.31%	Perf Quarter	2.54%
Income	1.90B	P/S	0.19	EPS this Y	15.86%	Inst Trans	-0.03%	Short Ratio	4.72	Perf Half Y	18.17%
Sales	316.65B	P/B	29.62	EPS next Y	9.31%	ROA	2.70%	Short Interest	6.14M	Perf YTD	34.64%
Book/sh	10.21	P/C	25.78	EPS next 5Y	11.62%	ROE	130.60%	52W High	309.35 -2.21%	Perf Year	27.36%
Cash/sh	11.74	P/FCF	51.38	EPS past 3/5Y	0.66% 13.29%	ROIC	18.93%	52W Low	218.65 38.36%	Perf 3Y	104.63%
Dividend Est.	2.22 (0.73%)	EV/EBITDA	14.28	Sales past 3/5Y	11.16% 10.36%	Gross Margin	3.06%	Volatility	2.10% 1.97%	Perf 5Y	213.17%
Dividend TTM	2.20 (0.73%)	EV/Sales	0.20	EPS Y/Y TTM	5.31%	Oper. Margin	1.09%	ATR (14)	5.94	Perf 10Y	202.52%
Dividend Ex-Date	Aug 15, 2025	Quick Ratio	0.53	Sales Y/Y TTM	11.56%	Profit Margin	0.60%	RSI (14)	60.43	Recom	1.71
Dividend Gr. 3/5Y	5.04% 4.98%	Current Ratio	0.90	EPS Q/Q	45.69%	SMA20	2.53%	Beta	0.62	Target Price	338.38
Payout	27.07%	Debt/Eq	4.16	Sales Q/Q	8.65%	SMA50	3.12%	Rel Volume	0.85	Prev Close	302.80
Employees	46000	LT Debt/Eq	4.06	Earnings	Aug 06 BMO	SMA200	11.36%	Avg Volume	1.30M	Price	302.52
IPO	Apr 04, 1995	Option/Short	Yes / Yes	EPS/Sales Surpr.	3.96% 0.71%	Trades		Volume	1,189,360	Change	-0.09%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-03-25	Upgrade	Wells Fargo	Equal Weight → Overweight	$337
Dec-04-24	Resumed	Mizuho	Outperform	$280
Sep-18-24	Downgrade	BofA Securities	Buy → Neutral	$275 → $245
Feb-26-24	Initiated	Leerink Partners	Outperform	$261
Jan-03-24	Initiated	Barclays	Overweight	$242
Dec-14-23	Initiated	Wells Fargo	Equal Weight	$213
Mar-31-23	Initiated	Citigroup	Buy	$185
Jan-31-23	Resumed	Evercore ISI	Outperform	$185
Oct-11-22	Upgrade	BofA Securities	Neutral → Buy	$160 → $169
Aug-22-22	Resumed	Morgan Stanley	Equal-Weight
Jul-11-22	Downgrade	Evercore ISI	Outperform → In-line	$150
Jun-07-22	Upgrade	Deutsche Bank	Hold → Buy	$167 → $178
May-26-22	Upgrade	Barclays	Equal Weight → Overweight
Apr-12-22	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$178
Apr-01-22	Resumed	Credit Suisse	Outperform	$180
Feb-04-21	Upgrade	Evercore ISI	In-line → Outperform
Jan-06-21	Upgrade	BofA Securities	Underperform → Neutral
Jun-15-20	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$112
Apr-23-20	Resumed	Credit Suisse	Outperform	$105
Apr-01-20	Upgrade	JP Morgan	Neutral → Overweight	$93 → $106

Show Previous Ratings

Sep-12-25 05:37AM	PACS Group, Inc. (PACS) Soars 24.5%: Is Further Upside Left in the Stock? (Zacks)
Sep-10-25 09:45AM	Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
Sep-05-25 08:06AM	Here's Why You Should Hold Cencora Stock in Your Portfolio Now (Zacks)
Sep-01-25 09:40AM	Here's Why Cencora (COR) is a Strong Value Stock (Zacks)
Aug-28-25 11:40AM	COR vs. MEDP: Which Stock Is the Better Value Option? (Zacks)
09:17AM	Loading…
09:17AM	Add These 4 GARP Stocks to Your Portfolio to Receive Handsome Returns (Zacks)
Aug-27-25 04:15PM	Cencora Appoints Mark Durcan as Chairman of Its Board of Directors (Business Wire)
12:45PM	Cencora (COR) is an Incredible Growth Stock: 3 Reasons Why (Zacks)
Aug-26-25 04:54PM	Analyst Report: McKesson Corporation (Morningstar Research)
09:50AM	Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
Aug-20-25 09:40AM	Is Climb Bio, Inc. (CLYM) Outperforming Other Medical Stocks This Year? (Zacks)
Aug-19-25 09:45AM	Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio (Zacks)
Aug-18-25 05:57AM	Cencora directors agree to $111M settlement over alleged opioid mismanagement (Healthcare Dive)
Aug-15-25 09:40AM	Why Cencora (COR) is a Top Value Stock for the Long-Term (Zacks)
Aug-13-25 11:34PM	Health Insurance Providers Stocks Q2 Teardown: Cencora (NYSE:COR) Vs The Rest (StockStory)
09:44AM	Loading…
09:44AM	Cencora Stock: Analyst Estimates & Ratings (Barchart)
01:34AM	The 5 Most Interesting Analyst Questions From Cencora's Q2 Earnings Call (StockStory)
Aug-12-25 05:14PM	Analyst Report: Cardinal Health, Inc. (Morningstar Research)
03:16AM	COR Q2 Deep Dive: Specialty Growth, International Headwinds, and Guidance Update (StockStory)
Aug-11-25 12:45PM	3 Reasons Growth Investors Will Love Cencora (COR) (Zacks)
Aug-08-25 09:39AM	Can Sustained Product Demand Drive CAH Stock Before Q4 Earnings? (Zacks)
Aug-07-25 07:44PM	Analyst Report: Cardinal Health, Inc. (Morningstar Research)
11:00AM	ZBH Stock Gains On Q2 Earnings and Revenue Beat, '25 EPS View Up (Zacks)
08:18AM	STE Beats on Q1 Earnings and Revenues, Raises '26 Sales View (Zacks)
Aug-06-25 09:02PM	Analyst Report: McKesson Corporation (Morningstar Research)
07:36PM	Analyst Report: Cencora, Inc. (Morningstar Research)
05:26PM	Mckesson lifts annual profit forecast on robust demand for specialty drugs (Reuters)
01:13PM	Cencora Says Famed GLP-1 Class Products Drive Growth, Boosts Profit Outlook (Benzinga)
10:28AM	COR Q3 Earnings & Revenues Beat Estimates, '25 EPS View Raised (Zacks)
09:30AM	Cencora (COR) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
09:24AM	Loading…
09:24AM	CRL Stock Gains on Q2 Earnings and Revenue Beat, Raises '25 View (Zacks)
07:40AM	Cencora (COR) Q3 Earnings and Revenues Surpass Estimates (Zacks)
06:48AM	Cencora's (NYSE:COR) Q2 Sales Top Estimates (StockStory)
06:44AM	Cencora: Fiscal Q3 Earnings Snapshot (Associated Press Finance)
06:30AM	Cencora Reports Fiscal 2025 Third Quarter Results (Business Wire)
Aug-05-25 09:05AM	Henry Schein Stock Falls on Q2 Earnings Miss, Revenues Top (Zacks)
Aug-04-25 11:11PM	What To Expect From Cencora's (COR) Q2 Earnings (StockStory)
12:08PM	Can Specialty and GLP-1 Momentum Support Cencora's Q3 Results? (Zacks)
08:35AM	DENTSPLY SIRONA to Post Q2 Earnings: What's in Store for the Stock? (Zacks)
08:30AM	Zimmer Biomet to Report Q2 Earnings: Here's What to Expect (Zacks)
08:00AM	Mallinckrodt Names Leslie Donato to Board of Directors (PR Newswire)
Aug-01-25 09:15AM	Gear Up for Cencora (COR) Q3 Earnings: Wall Street Estimates for Key Metrics (Zacks)
08:50AM	Will Healthcare Growth Help STE Beat on Q1 Earnings? (Zacks)
08:50AM	SYK Stock Falls Despite Q2 Earnings & Sales Beat, '25 View Up (Zacks)
Jul-31-25 11:40AM	BAX Stock Falls Following Q2 Earnings & Sales Miss, '25 EPS View Down (Zacks)
10:01AM	CVS Stock Up on Q2 Earnings & Revenue Beat, '25 EPS View Raised (Zacks)
10:00AM	Progyny (PGNY) Earnings Expected to Grow: Should You Buy? (Zacks)
08:48AM	DexCom Stock Falls Despite Q2 Earnings Beat & 2025 Sales View Raise (Zacks)
08:46AM	ALGN Stock Falls on Q2 Earnings and Revenue Miss, Margins Down (Zacks)
Jul-30-25 10:00AM	Cencora (COR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
08:20AM	Charles River Q2 Earnings Preview: What's in Store for the Stock? (Zacks)
05:13AM	Elevance names former Cencora CEO to board (Healthcare Dive)
Jul-29-25 06:05PM	Teladoc (TDOC) Reports Q2 Loss, Beats Revenue Estimates (Zacks)
09:49AM	WGS Stock Gains on Q2 Earnings and Revenue Beat, Raises '25 Sales View (Zacks)
09:40AM	Are Medical Stocks Lagging McKesson (MCK) This Year? (Zacks)
08:54AM	Will SYK's Q2 Earnings Reflect Strong Growth Despite Tariff Overhang? (Zacks)
08:07AM	Henry Schein to Report Q2 Earnings: What's in Store for the Stock? (Zacks)
Jul-28-25 12:41PM	Baxter Q2 Preview: Can Core Segments Deliver Another Solid Quarter? (Zacks)
12:38PM	Should You Buy, Sell, or Hold GE Healthcare Before Q2 Earnings? (Zacks)
10:11AM	RVTY Posts Q2 Earnings & Sales Beat, Raises '25 Sales View (Zacks)
09:26AM	Will Exome and Genome Growth Boost WGS' Q2 Earnings? (Zacks)
07:56AM	IDEXX to Release Q2 Earnings: What's in Store for the Stock? (Zacks)
06:57AM	Cell and Gene Therapy Third-Party Logistics Market Forecast and Company Analysis Report 2025-2033 Featuring Cencora, Cardinal Health, McKesson, EVERSANA, Knipper Health, Arvato, DHL, and Kuehne+Nagel (GlobeNewswire)
Jul-25-25 12:23PM	Integer Holdings Q2 Earnings Miss Estimates, Revenues Up Y/Y (Zacks)
08:42AM	EW Stock Climbs on Q2 Earnings & Revenue Beat, Margins Down (Zacks)
Jul-24-25 11:11AM	Revvity Q2 Preview: Can Strong Segments Deliver an Earnings Beat? (Zacks)
10:46AM	WST Stock Rises on Q2 Earnings Beat, EPS View Up on Tariff & FX Benefit (Zacks)
10:25AM	Cencora, Inc. (COR): A Bull Case Theory (Insider Monkey)
10:15AM	Will DXCM Q2 Earnings Reflect U.S. Coverage Expansion & Stelo Impact? (Zacks)
10:08AM	Can Robust Invisalign Momentum Drive Align Technology's Q2 Earnings? (Zacks)
Jul-23-25 11:59AM	Boston Scientific Beats on Q2 Earnings, Raises 2025 View, Stock Up (Zacks)
10:01AM	Universal Health to Report Q2 Earnings: What Do the Key Estimates Say? (Zacks)
08:35AM	ISRG Stock Gains on Q2 Earnings & Sales Beat, Gross Margin Contracts (Zacks)
Jul-22-25 12:11PM	WST Q2 Earnings Preview: Will the Stock's Segmental Edge Hold Up? (Zacks)
10:01AM	Farmina Pet Foods Expands U.S. Veterinary Presence with National Distribution Agreement with MWI Animal Health (PR Newswire)
08:39AM	Quest Diagnostics Beats Q2 Earnings & Revenue Estimates, Stock Rises (Zacks)
07:43AM	Robust TMTT Growth to Drive Edwards Lifesciences' Q2 Earnings (Zacks)
Jul-21-25 10:35AM	HCA Healthcare to Report Q2 Earnings: Key Estimates to Note (Zacks)
08:38AM	ECL Unveils ReadyDose Cleaning Program for Southeast Asian Restaurants (Zacks)
08:30AM	Labcorp Q2 Earnings Preview: Diagnostics Strength in Focus (Zacks)
08:05AM	DGX Q2 Earnings Preview: Will Advanced Diagnostics Lead Performance? (Zacks)
Jul-18-25 12:03PM	Molina to Report Q2 Earnings: Healthy Revenues, Weak Pulse on Earnings (Zacks)
12:00PM	Good Neighbor Pharmacy Celebrates Independent Community Pharmacy Excellence at ThoughtSpot 2025 (Business Wire)
11:26AM	Danaher Gears Up to Post Q2 Earnings: What Lies Ahead for the Stock? (Zacks)
10:26AM	Here's Why You Should Hold Accuray Stock in Your Portfolio for Now (Zacks)
08:35AM	TMO to Report Q2 Earnings: Analytical Instruments Segment in Focus (Zacks)
08:27AM	Should You Add Edwards Lifesciences Stock to Your Portfolio Now? (Zacks)
Jul-17-25 11:33AM	ISRG's Vessel Sealer Curved for da Vinci Systems Gets FDA Approval (Zacks)
Jul-16-25 12:35PM	ANGO Stock Down Despite Q4 Earnings Beat, Gross Margin Declines (Zacks)
12:26PM	Reasons to Add DENTSPLY SIRONA Stock to Your Portfolio Now (Zacks)
09:42AM	Here's Why You Should Add Inogen Stock to Your Portfolio Now (Zacks)
09:04AM	GMED Unveils Next-Gen Oscillating System DuraPro: Stock to Gain? (Zacks)
08:38AM	Should You Continue to Hold Veracyte Stock in Your Portfolio Now? (Zacks)
08:19AM	Is it Prudent to Retain Charles River Stock in Your Portfolio Now? (Zacks)
06:20AM	Should Franklin U.S. Mid Cap Multifactor Index ETF (FLQM) Be on Your Investing Radar? (Zacks)
Jul-15-25 01:37PM	Sightview Expands Leadership Bench, Appointing Vice Presidents of Client Operations and Product Management (Business Wire)
09:12AM	BD Partners With Waters to Build High-Volume Diagnostics Leader (Zacks)
09:02AM	Will Robust MedSurg Performance Fuel Boston Scientific's Q2 Earnings? (Zacks)
Jul-14-25 08:29AM	ABT to Report Q2 Earnings: CGM and Cardiac Devices in Focus (Zacks)
08:07AM	Bio-Rad Stock Climbs Following the Launch of Four ddPCR Platforms (Zacks)

Cencora, Inc. is a pharmaceutical sourcing and distribution services company. It operates through the United States (U.S.) Healthcare Solutions and International Healthcare Solutions segments. The U.S. Healthcare Solutions segment is involved in the offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a wide variety of healthcare providers. The International Healthcare Solutions segment includes businesses that focus on international pharmaceutical wholesale and related service operations, and global commercialization services. The company was founded by Emil P. Martini in 1947 and is headquartered in Conshohocken, PA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
COLLIS STEVEN H	Executive Chairman	Aug 19 '25	Option Exercise	86.09	12,579	1,082,926	322,492	Aug 20 04:08 PM
COLLIS STEVEN H	Executive Chairman	Aug 19 '25	Sale	289.98	14,579	4,227,618	307,913	Aug 20 04:08 PM
Mauch Robert P.	President & CEO	Aug 18 '25	Option Exercise	86.09	3,225	277,640	45,576	Aug 20 04:06 PM
Mauch Robert P.	President & CEO	Aug 18 '25	Sale	293.53	4,968	1,458,257	40,608	Aug 20 04:06 PM
COLLIS STEVEN H	Director	Aug 19 '25	Proposed Sale	289.98	14,579	4,227,618		Aug 19 09:51 AM
Mauch Robert P.	Officer	Aug 18 '25	Proposed Sale	293.53	4,968	1,458,257		Aug 18 11:06 AM
COLLIS STEVEN H	Executive Chairman	Jul 22 '25	Option Exercise	86.09	12,578	1,082,840	324,491	Jul 23 04:30 PM
COLLIS STEVEN H	Executive Chairman	Jul 22 '25	Sale	292.67	14,578	4,266,543	309,913	Jul 23 04:30 PM
Mauch Robert P.	President & CEO	Jul 18 '25	Option Exercise	86.09	3,225	277,640	47,319	Jul 22 04:23 PM
Mauch Robert P.	President & CEO	Jul 18 '25	Sale	294.11	4,968	1,461,138	42,351	Jul 22 04:23 PM
COLLIS STEVEN H	Director	Jul 22 '25	Proposed Sale	292.67	14,578	4,266,543		Jul 22 09:47 AM
Mauch Robert P.	Officer	Jul 18 '25	Proposed Sale	294.11	4,968	1,461,138		Jul 18 11:44 AM
COLLIS STEVEN H	Executive Chairman	Jun 24 '25	Option Exercise	86.09	12,579	1,082,926	326,492	Jun 25 04:03 PM
COLLIS STEVEN H	Executive Chairman	Jun 24 '25	Sale	292.62	14,579	4,266,107	311,913	Jun 25 04:03 PM
COLLIS STEVEN H	Director	Jun 24 '25	Proposed Sale	292.62	14,579	4,266,107		Jun 24 10:21 AM
Battaglia Silvana	Executive Vice President	Jun 18 '25	Sale	297.40	4,077	1,212,520	11,297	Jun 20 04:06 PM
Mauch Robert P.	President & CEO	Jun 18 '25	Option Exercise	86.09	3,225	277,640	49,063	Jun 20 04:04 PM
Mauch Robert P.	President & CEO	Jun 18 '25	Sale	295.30	4,969	1,467,346	44,094	Jun 20 04:04 PM
Lon Greenberg	Board of directors	Jun 18 '25	Proposed Sale	293.20	1,000	293,200		Jun 18 04:40 PM
Battaglia Silvana	Officer	Jun 18 '25	Proposed Sale	297.41	4,077	1,212,520		Jun 18 12:58 PM
Mauch Robert P.	Officer	Jun 18 '25	Proposed Sale	295.30	4,969	1,467,346		Jun 18 09:50 AM
Krikorian Lazarus	SVP & Chief Accounting Officer	May 29 '25	Sale	288.96	3,000	866,881	17,154	Jun 02 04:08 PM
Krikorian Lazarus	Officer	May 29 '25	Proposed Sale	288.96	3,000	866,881		May 29 11:37 AM
Mauch Robert P.	President & CEO	May 19 '25	Option Exercise	86.09	3,225	277,640	50,807	May 21 04:04 PM
Mauch Robert P.	President & CEO	May 19 '25	Sale	291.43	4,969	1,448,116	45,838	May 21 04:04 PM
COLLIS STEVEN H	Executive Chairman	May 20 '25	Option Exercise	86.09	12,578	1,082,840	328,491	May 21 04:00 PM
COLLIS STEVEN H	Executive Chairman	May 20 '25	Sale	293.84	14,578	4,283,600	313,913	May 21 04:00 PM
COLLIS STEVEN H	Director	May 20 '25	Proposed Sale	293.84	14,578	4,283,600		May 20 09:45 AM
Hopfield Jessica	Member of immediate family of	May 19 '25	Proposed Sale	293.24	12,185	3,573,163		May 19 02:29 PM
Mauch Robert P.	Officer	May 19 '25	Proposed Sale	291.43	4,969	1,448,116		May 19 09:51 AM
GREENBERG LON R	Director	May 14 '25	Sale	279.05	3,000	837,150	17,851	May 16 04:23 PM
GREENBERG LON R	Director	May 14 '25	Proposed Sale	279.05	3,000	837,150		May 14 03:53 PM
COLLIS STEVEN H	Executive Chairman	Apr 22 '25	Option Exercise	86.09	12,579	1,082,926	330,492	Apr 23 04:24 PM
COLLIS STEVEN H	Executive Chairman	Apr 22 '25	Sale	281.81	14,579	4,108,508	315,913	Apr 23 04:24 PM
Mauch Robert P.	President & CEO	Apr 21 '25	Option Exercise	86.09	3,225	277,640	52,551	Apr 22 04:06 PM
Mauch Robert P.	President & CEO	Apr 21 '25	Sale	289.33	4,969	1,437,681	47,582	Apr 22 04:06 PM
COLLIS STEVEN H	Director	Apr 22 '25	Proposed Sale	281.81	14,579	4,108,508		Apr 22 09:42 AM
Mauch Robert P.	Officer	Apr 21 '25	Proposed Sale	289.33	4,969	1,437,681		Apr 21 09:48 AM
COLLIS STEVEN H	Executive Chairman	Mar 25 '25	Option Exercise	86.09	12,578	1,082,840	332,491	Mar 26 04:40 PM
COLLIS STEVEN H	Executive Chairman	Mar 25 '25	Sale	269.51	14,578	3,928,917	317,913	Mar 26 04:40 PM
Campbell Elizabeth S	Executive Vice President	Mar 24 '25	Sale	268.28	4,127	1,107,192	14,665	Mar 26 04:38 PM
COLLIS STEVEN H	Director	Mar 25 '25	Proposed Sale	269.51	14,578	3,928,917		Mar 25 10:16 AM
Campbell Elizabeth S	Officer	Mar 24 '25	Proposed Sale	268.28	4,127	1,107,192		Mar 24 10:53 AM
Mauch Robert P.	President & CEO	Mar 18 '25	Option Exercise	86.09	3,226	277,726	54,296	Mar 19 04:38 PM
Mauch Robert P.	President & CEO	Mar 18 '25	Sale	260.93	4,970	1,296,822	49,326	Mar 19 04:38 PM
Mauch Robert P.	Officer	Mar 18 '25	Proposed Sale	260.93	4,970	1,296,822		Mar 18 12:05 PM
Krikorian Lazarus	SVP & Chief Accounting Officer	Mar 10 '25	Sale	260.06	2,000	520,120	20,154	Mar 11 04:07 PM
Krikorian Lazarus	Officer	Mar 10 '25	Proposed Sale	260.06	2,000	520,120		Mar 10 02:09 PM
Mauch Robert P.	President & CEO	Mar 03 '25	Option Exercise	86.09	3,226	277,726	54,296	Mar 04 05:35 PM
Mauch Robert P.	President & CEO	Mar 03 '25	Sale	255.00	4,970	1,267,350	51,070	Mar 04 05:35 PM
Mauch Robert P.	Officer	Mar 03 '25	Proposed Sale	255.00	4,970	1,267,350		Mar 03 03:28 PM
COLLIS STEVEN H	Executive Chairman	Feb 27 '25	Option Exercise	86.09	12,579	1,082,926	332,492	Feb 28 04:05 PM
COLLIS STEVEN H	Executive Chairman	Feb 27 '25	Sale	251.08	14,579	3,660,495	319,913	Feb 28 04:05 PM
COLLIS STEVEN H	Director	Feb 27 '25	Proposed Sale	251.08	14,579	3,660,495		Feb 27 11:26 AM
Battaglia Silvana	Executive Vice President	Feb 21 '25	Sale	242.24	5,000	1,211,200	15,374	Feb 24 05:25 PM
Battaglia Silvana	Officer	Feb 21 '25	Proposed Sale	242.24	5,000	1,211,200		Feb 21 12:18 PM
Walgreens Boots Alliance, Inc.	10% Owner	Feb 06 '25	Sale	244.51	1,286,376	314,531,796	12,570,000	Feb 10 07:35 PM
Walgreens Boots Alliance Holdi	Affiliate	Feb 06 '25	Proposed Sale	246.13	1,081,885	266,284,355		Feb 06 07:55 PM
Battaglia Silvana	Executive Vice President	Dec 20 '24	Sale	228.72	1,678	383,792	20,329	Dec 23 03:47 PM
Battaglia Silvana	Officer	Dec 20 '24	Proposed Sale	228.72	1,678	383,792		Dec 20 01:48 PM
Krikorian Lazarus	SVP & Chief Accounting Officer	Dec 03 '24	Sale	250.41	1,816	454,754	21,988	Dec 04 04:22 PM
Krikorian Lazarus	Officer	Dec 03 '24	Proposed Sale	250.42	1,816	454,754		Dec 03 11:13 AM
Cleary James F	Chief Financial Officer	Nov 27 '24	Option Exercise	89.58	33,877	3,034,702	171,508	Dec 02 04:01 PM
COLLIS STEVEN H	Executive Chairman	Nov 25 '24	Sale	243.97	50,000	12,198,750	326,557	Nov 26 04:31 PM
COLLIS STEVEN H	Director	Nov 25 '24	Proposed Sale	243.98	50,000	12,198,760		Nov 25 04:04 PM
COLLIS STEVEN H	Executive Chairman	Nov 19 '24	Option Exercise	89.58	21,509	1,926,776	328,261	Nov 21 04:49 PM
COLLIS STEVEN H	Executive Chairman	Nov 19 '24	Sale	242.16	21,509	5,208,619	306,752	Nov 21 04:49 PM
COLLIS STEVEN H	Director	Nov 19 '24	Proposed Sale	242.16	21,509	5,208,619		Nov 19 10:00 AM
COLLIS STEVEN H	Executive Chairman	Oct 22 '24	Option Exercise	89.58	21,509	1,926,776	306,597	Oct 23 04:06 PM
COLLIS STEVEN H	Executive Chairman	Oct 22 '24	Sale	235.80	21,509	5,071,822	285,088	Oct 23 04:06 PM
COLLIS STEVEN H	Officer	Oct 22 '24	Proposed Sale	235.80	21,509	5,071,822		Oct 22 10:43 AM
COLLIS STEVEN H	Chairman, President & CEO	Sep 17 '24	Option Exercise	89.58	21,509	1,926,776	306,597	Sep 18 04:37 PM
COLLIS STEVEN H	Chairman, President & CEO	Sep 17 '24	Sale	241.01	21,509	5,183,884	285,088	Sep 18 04:37 PM
Lon Greenberg	Other: Board	Sep 17 '24	Proposed Sale	239.88	4,000	959,520		Sep 17 05:27 PM
COLLIS STEVEN H	Officer	Sep 17 '24	Proposed Sale	241.01	21,509	5,183,884		Sep 17 09:36 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

COR

Cencora Inc

Upgrade your FINVIZ experience